Calcium channel blocker: Difference between revisions
No edit summary |
No edit summary |
||
| (9 intermediate revisions by the same user not shown) | |||
| Line 88: | Line 88: | ||
| | | | ||
|- | |- | ||
|} | |||
{| class="wikitable sortable" style="width:100%" | |||
|+非ジヒドロビリジン系 | |||
|- | |||
!一般名 | |||
!先発名 | |||
!class="unsortable"| 日本 | |||
!創薬/開発 | |||
!備考 | |||
|- | |||
|[[Verapamil/ja]] | |||
|[https://medical.eisai.jp/products/va/va_t40 ワソラン](Vasolan) ([https://pins.japic.or.jp/pdf/newPINS/00052429.pdf PI]) ([https://medical2.eisai.jp/fileviewer/pdf_downloader.php?access_key=fywpgjbm9d IF]) | |||
|販売 | |||
|[[:de:Siegfried PharmaChemikalien Minden|Knoll AG(独)]] | |||
|フェネチルアミン系。<br />適応:頻脈性不整脈、狭心症、心筋梗塞 | |||
|- | |||
|[[Diltiazem/ja]] | |||
|[https://medical.mt-pharma.co.jp/di/product/her/ ヘルベッサー](Herbesser) ([https://pins.japic.or.jp/pdf/newPINS/00050628.pdf PI]) ([https://medical.mt-pharma.co.jp/di/file/if/f_her_d.pdf IF]) | |||
|販売 | |||
|[[Mitsubishi Tanabe Pharma|田辺製薬]] | |||
|ベンゾチアゼピン系。持効製剤のRと注射剤もあり | |||
|- | |||
|} | |||
{| class="wikitable sortable" style="width:100%" | |||
|+配合剤 | |||
|- | |||
!配合薬 | |||
!一般名 | |||
!先発名 | |||
!class="unsortable"| 日本 | |||
!創薬/開発 | |||
!備考 | |||
|- | |||
|[[Statin/ja|スタチン]] | |||
|[[Amlodipine/ja|アムロジピン]]・[[Atorvastatin/ja|アトルバスタチン]] | |||
|[https://www.viatris-e-channel.com/viatris-products/di/detail/4987901001205.html カデュエット](Caduet) ([https://pins.japic.or.jp/pdf/newPINS/00057018.pdf PI]) ([https://www.viatris-e-channel.com/viatris-products/di/pdf/cad01if.pdf iF]) | |||
|販売 | |||
|[[Phizer]] | |||
| | |||
|} | |} | ||
<languages /> | <languages /> | ||